SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16527)12/22/2003 2:04:33 AM
From: aknahow  Read Replies (2) | Respond to of 17367
 
Robert, you believe in BPI. Bluegreen believes. I believe. That makes three that believe. Years ago I suggested Xoma license BPI for combo use for any antibiotic. up front license fees plus royalties just the same as cell expression or H.E. technology.

I just don't think Xoma shares our interest. If they shared it would they run around trying to do partnerships with everyone or would they just spend more time working on BPI?



To: Robert K. who wrote (16527)1/21/2004 12:23:35 AM
From: Bluegreen  Read Replies (3) | Respond to of 17367
 
Bob, I thought you might need a little education about CF and ANCA.LOL Enjoy>>>>>>>>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14730661&dopt=Abstract


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News